longbridge

荣昌生物

688331
----

全部股东

股东类型

  • 公众及其他38.54%
  • 员工持股计划26.59%
  • 机构投资者23.05%
  • 个人与内部人士11.82%

主要股东

主要股东 最新
股东
RemeGen Co., Ltd , ESOP
26.59%1.49 亿0.00%+0
Jianmin FangCo-Founder, CEO, GM, Member of Scientific Advisory Board & Executive Director
10.64%5,956.33 万0.00%+0
China Universal Asset Management Company Ltd.
3.41%1,911.56 万0.26%+147.70 万
BlackRock, Inc.
1.84%1,028.13 万0.04%+24.68 万
Allianz Asset Management GmbH
1.69%944.87 万0.00%+0
Vanguard Capital Management, LLC
1.60%896.99 万0.02%+12.75 万
GF Fund Management Co., Ltd.
1.48%829.96 万0.00%+0
ICBC Credit Suisse Fund Management Co., Ltd
1.23%688.32 万0.00%+0
Weidong WangCo-Founder & Executive Chairman
1.15%644.44 万0.00%+0
Yinhua Fund Management Co., Ltd.
0.94%523.83 万0.00%+0
Bank of China Investment Management Co., Ltd.
0.82%461.31 万0.00%+0
China Southern Asset Management Co., Ltd.
0.73%410.76 万0.00%+0
E Fund Management Co., Ltd.
0.73%406.29 万<0.01%+671.00
HuaAn Fund Management Company Ltd.
0.71%394.98 万0.00%+0
Wanjia Asset Management Co., Ltd.
0.67%372.50 万0.27%-150.00 万
Maxwealth Fund Management Co., Ltd
0.66%370.89 万0.17%-96.50 万
Morgan Stanley
0.55%306.99 万0.00%+0
China Merchants Fund Management Company Ltd.
0.50%282.25 万0.00%+0
Fullgoal Fund Management Co. Ltd.
0.46%258.38 万0.00%+0
China Asset Management Co. Ltd.
0.35%197.36 万0.00%+0
© 2026 Longbridge｜服务条款隐私政策